GlassScriptPhysician profile
Amy Grimes
NPI 1639409113
$3,840.08
in general payments reported to CMS, 2019-2025
18 companies · $708 in 2025
The $708 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,215 · 2022: $808 · 2023: $443 · 2024: $666 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,816.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,701.29 | 2021-2025 | Tezspire, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $548.88 | 2021-2023 | Nucala |
| Paratek Pharmaceuticals, INC. | $275.56 | 2021-2022 | |
| Grifols USA, LLC | $199.34 | 2024-2025 | Prolastin-C Liquid |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.35 | 2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.40 | 2021-2023 | |
| Jazz Pharmaceuticals INC. | $137.50 | 2021 | |
| United Therapeutics Corporation | $133.56 | 2022 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2024 | Xarelto |
| Verona Pharma, INC. | $124.61 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $67.78 | 2024 | Inspire |
| Actelion Pharmaceuticals US, INC. | $55.79 | 2022-2023 | Opsumit, Uptravi |
| Baxter Healthcare | $35.32 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $33.71 | 2022-2025 | Smartvest |
| Pharming Healthcare, INC. | $23.96 | 2023 | Ruconest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $20.45 | 2023 | Yupelri |
| Genzyme Corporation | $14.42 | 2022 | |
| Pfizer INC. | $14.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Grimes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.